electroCore, Inc. (ECOR) Quick Ratio
- Quick ratio · latest quarter: Value 0.94×; Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | 0.94× | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. $10.95M ÷ $11.67M ≈ 0.94× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | 10.95M USD | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current · Debt Securities, Available-for-sale, Current · Available-for-sale Securities, Current · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 11.67M USD | Liabilities, Current |
| Cash and equivalents | 8.50M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 1.54M USD | Marketable Securities, Current · Debt Securities, Available-for-sale, Current · Available-for-sale Securities, Current |
| Customer receivables | 909.00K USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 2.42M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $10.95M | $11.67M | $8.50M | $1.54M | $909.00K | $2.42M | 0.94× |
| 2026-03-31 | $9.70M | $12.31M | $4.85M | $3.98M | $872.00K | $1.98M | 0.79× |
| 2025-12-31 | $12.64M | $11.35M | $7.04M | $4.58M | $1.03M | $1.63M | 1.11× |
| 2025-09-30 | $14.43M | $12.14M | $7.86M | $5.09M | $1.48M | $1.21M | 1.19× |
| 2025-06-30 | $7.96M | $9.62M | $3.37M | $3.77M | $813.00K | $1.43M | 0.83× |
| 2025-03-31 | $9.22M | $7.86M | $3.78M | $3.98M | $1.46M | $1.73M | 1.17× |
| 2024-12-31 | $13.34M | $9.15M | $3.45M | $8.52M | $1.37M | $1.68M | 1.46× |
| 2024-09-30 | $13.50M | $7.91M | $4.93M | $8.02M | $552.00K | $1.96M | 1.71× |
| 2024-06-30 | $14.77M | $7.25M | $10.30M | $3.93M | $538.00K | $2.58M | 2.04× |
| 2024-03-31 | (m) | $7.83M | $7.85M | (m) | $475.00K | $2.51M | (m) |
| 2023-12-31 | (m) | $8.12M | $10.33M | (m) | $717.00K | $2.16M | (m) |
| 2023-09-30 | (m) | $8.51M | $13.46M | (m) | $589.00K | $2.50M | (m) |
| 2023-06-30 | (m) | $6.58M | $8.44M | (m) | $238.00K | $2.37M | (m) |
| 2023-03-31 | (m) | $5.85M | $11.91M | (m) | $213.00K | $2.48M | (m) |
| 2022-12-31 | (m) | $7.04M | $17.71M | (m) | $401.00K | $1.98M | (m) |
| 2022-09-30 | (m) | $6.64M | $21.64M | (m) | $364.00K | $1.97M | (m) |
| 2022-06-30 | (m) | $5.64M | $26.33M | (m) | $575.00K | $1.74M | (m) |
| 2022-03-31 | (m) | $4.68M | $29.88M | (m) | $364.00K | $1.58M | (m) |
| 2021-12-31 | (m) | $5.49M | $34.69M | (m) | $438.24K | $1.36M | (m) |
| 2021-09-30 | $39.33M | $5.74M | $38.00M | $1.00M | $329.78K | $1.08M | 6.85× |
| 2021-06-30 | $24.10M | $5.76M | $14.70M | $9.03M | $369.19K | $1.08M | 4.19× |
| 2021-03-31 | $25.71M | $5.34M | $9.06M | $16.39M | $259.32K | $944.72K | 4.81× |
| 2020-12-31 | $22.90M | $5.89M | $4.24M | $18.39M | $270.55K | $876.44K | 3.89× |
| 2020-09-30 | $26.14M | $5.81M | $3.83M | $22.14M | $175.95K | $793.22K | 4.50× |
| 2020-06-30 | $18.98M | $5.08M | $14.86M | $4.00M | $119.49K | $761.30K | 3.74× |
| 2020-03-31 | (m) | $7.35M | $15.62M | (m) | $272.04K | $664.37K | (m) |
| 2019-12-31 | $24.56M | $9.14M | $13.56M | $10.50M | $496.14K | $890.99K | 2.69× |
| 2019-09-30 | $34.24M | $10.25M | $6.55M | $26.94M | $753.38K | $3.11M | 3.34× |
| 2019-06-30 | $41.64M | $7.11M | $8.73M | $32.40M | $500.97K | $5.00M | 5.85× |
| 2019-03-31 | $52.66M | $5.33M | $6.95M | $45.41M | $288.33K | $3.59M | 9.88× |
| 2018-12-31 | $68.83M | $7.07M | $7.60M | $60.96M | $267.60K | $1.95M | 9.73× |
| 2018-09-30 | $80.74M | $4.77M | $26.26M | $54.25M | $227.31K | $1.12M | 16.94× |
| 2018-06-30 | $96.12M | $6.91M | $88.36M | $7.47M | $298.24K | $751.95K | 13.90× |
| 2018-03-31 | (m) | (m) | $1.52M | (m) | (m) | (m) | (m) |
| 2017-12-31 | $37.28M | $6.12M | $13.22M | $23.95M | $103.21K | $327.79K | 6.09× |
| 2017-09-30 | (m) | (m) | $9.39M | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | $8.56M | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | (m) | $416.34K | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |